SUPTEK

Suptek is a clinical-stage biopharmaceutical company focused on the development of innovative drug delivery systems using its proprietary Supercritical Fluid (SCF) technology platform. The company specializes in creating high-end formulations of poorly soluble drugs to improve their bioavailability, safety, and efficacy. Suptek's pipeline primarily targets oncology and central nervous system disorders, with lead programs utilizing the 505(b)(2) regulatory pathway to enhance established therapeutics. By employing green chemistry principles, the company produces uniform drug particles without the need for toxic organic solvents. Suptek is headquartered in Suzhou, China, and is supported by prominent venture capital investors.